222 related articles for article (PubMed ID: 18632655)
1. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
Lee JM; Wong CM; Ng IO
Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of hepatocellular carcinoma.
Wong CM; Ng IO
Liver Int; 2008 Feb; 28(2):160-74. PubMed ID: 18069974
[TBL] [Abstract][Full Text] [Related]
3. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
4. Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.
Yeh SH; Chang CF; Shau WY; Chen YW; Hsu HC; Lee PH; Chen DS; Chen PJ
Cancer Res; 2002 Aug; 62(15):4346-51. PubMed ID: 12154039
[TBL] [Abstract][Full Text] [Related]
5. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
6. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
[TBL] [Abstract][Full Text] [Related]
8. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
[TBL] [Abstract][Full Text] [Related]
11. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
12. Genetic mechanisms of hepatocarcinogenesis.
Feitelson MA; Sun B; Satiroglu Tufan NL; Liu J; Pan J; Lian Z
Oncogene; 2002 Apr; 21(16):2593-604. PubMed ID: 11971194
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
[TBL] [Abstract][Full Text] [Related]
14. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
15. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
17. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
[TBL] [Abstract][Full Text] [Related]
18. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis.
Ng IO; Guan XY; Poon RT; Fan ST; Lee JM
J Pathol; 2003 Mar; 199(3):345-53. PubMed ID: 12579536
[TBL] [Abstract][Full Text] [Related]
19. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
20. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
